{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:27:53Z","timestamp":1783546073210,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jocn.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T04:46:06Z","timestamp":1649997966000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"100","author":[{"given":"Fardin","family":"Nabizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Nikfarjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sharifkazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sodeifian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2022.04.009_b0005","first-page":"483","article-title":"Pseudobulbar affect: prevalence and management","volume":"9","author":"Ahmed","year":"2013","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"10.1016\/j.jocn.2022.04.009_b0010","first-page":"31","article-title":"Review of the diagnosis and management of pseudobulbar affect","volume":"42","author":"Kim","year":"2017","journal-title":"US Pharm"},{"issue":"9","key":"10.1016\/j.jocn.2022.04.009_b0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12325-012-0043-7","article-title":"Pseudobulbar affect: burden of illness in the USA","volume":"29","author":"Colamonico","year":"2012","journal-title":"Adv Therapy"},{"issue":"6679","key":"10.1016\/j.jocn.2022.04.009_b0020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.298.6679.991","article-title":"Emotionalism after stroke","volume":"298","author":"House","year":"1989","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.jocn.2022.04.009_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/jnp.2009.21.1.75","article-title":"Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research","volume":"21","author":"Parvizi","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"7","key":"10.1016\/j.jocn.2022.04.009_b0030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/ern.11.68","article-title":"Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments","volume":"11","author":"Miller","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"10.1016\/j.jocn.2022.04.009_b0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2165\/11591450-000000000-00000","article-title":"Current concepts in the pharmacotherapy of pseudobulbar affect","volume":"71","author":"Pioro","year":"2011","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jocn.2022.04.009_b0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/jnp.17.4.447","article-title":"Review of pseudobulbar affect including a novel and potential therapy","volume":"17","author":"Schiffer","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.jocn.2022.04.009_b0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","article-title":"A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder","volume":"207","author":"Werling","year":"2007","journal-title":"Exp Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2022.04.009_b0050","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0091270004269521","article-title":"Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers","volume":"44","author":"Pope","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.jocn.2022.04.009_b0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12325-011-0031-3","article-title":"Pseudobulbar affect: an under-recognized and under-treated neurological disorder","volume":"28","author":"Work","year":"2011","journal-title":"Adv Therapy"},{"key":"10.1016\/j.jocn.2022.04.009_b0060","doi-asserted-by":"crossref","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","DOI":"10.1136\/bmj.b2700"},{"issue":"9","key":"10.1016\/j.jocn.2022.04.009_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3928\/02793695-20200624-08","article-title":"Pseudobulbar affect: an overview","volume":"58","author":"Goldin","year":"2020","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.jocn.2022.04.009_b0070","first-page":"23","article-title":"The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration","volume":"3","author":"King","year":"2013","journal-title":"Degenerative Neurol Neuromuscular Dis"},{"issue":"7113","key":"10.1016\/j.jocn.2022.04.009_b0075","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nature05293","article-title":"Cell death in the nervous system","volume":"443","author":"Bredesen","year":"2006","journal-title":"Nature"},{"issue":"7113","key":"10.1016\/j.jocn.2022.04.009_b0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jocn.2022.04.009_b0085","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.jocn.2022.04.009_b0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp-2017-315622","article-title":"Laughter, crying and sadness in ALS","volume":"88","author":"Thakore","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.jocn.2022.04.009_b0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/17482968.2010.536839","article-title":"Depression in amyotrophic lateral sclerosis","volume":"12","author":"Atassi","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"issue":"11","key":"10.1016\/j.jocn.2022.04.009_b0100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.0000000000002465","article-title":"Depression in ALS in a large self-reporting cohort","volume":"86","author":"Thakore","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jocn.2022.04.009_b0105","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-010-5550-3","article-title":"Pseudobulbar affect: prevalence and quality of life impact in movement disorders","volume":"257","author":"Strowd","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2022.04.009_b0110","doi-asserted-by":"crossref","unstructured":"Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE. PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS One 2013;8(8):e72232.","DOI":"10.1371\/journal.pone.0072232"},{"issue":"6","key":"10.1016\/j.jocn.2022.04.009_b0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1212\/CPJ.0000000000000523","article-title":"Pseudobulbar affect: prevalence and association with symptoms in multiple sclerosis","volume":"8","author":"Fitzgerald","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"9","key":"10.1016\/j.jocn.2022.04.009_b0120","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneur.1997.00550210050012","article-title":"Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis","volume":"54","author":"Feinstein","year":"1997","journal-title":"Arch Neurol"},{"issue":"S1","key":"10.1016\/j.jocn.2022.04.009_b0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1017\/S1092852916000791","article-title":"Recognizing and treating pseudobulbar affect","volume":"21","author":"Sauv\u00e9","year":"2016","journal-title":"CNS Spectr"},{"issue":"10","key":"10.1016\/j.jocn.2022.04.009_b0130","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1007\/s00415-012-6481-y","article-title":"Comparison of clinical characteristics between familial and non-familial early onset Alzheimer\u2019s disease","volume":"259","author":"Joshi","year":"2012","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2022.04.009_b0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/15622970701639445","article-title":"Inappropriate crying and laughing in Parkinson disease and movement disorders","volume":"10","author":"Siddiqui","year":"2009","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.jocn.2022.04.009_b0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00415-015-7981-3","article-title":"Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP)","volume":"263","author":"Tortelli","year":"2016","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2022.04.009_b0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14802\/jmd.18051","article-title":"Pseudobulbar affect in Parkinsonian disorders: a review","volume":"12","author":"Hakimi","year":"2019","journal-title":"JMD"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:30:56Z","timestamp":1760823056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S0967586822001679"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.04.009","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}